Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

CEL-SCI CORPORATION (CVM) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

CEL-SCI CORPORATION (CVM), most recent 12 months reported: net loss $22.7M, free cash flow -$16.75M. From SEC filings. Others in Biological Products, (No Diagnostic Substances): Cognition Therapeutics, Inc. · Calidi Biotherapeutics, Inc. · COMPASS THERAPEUTICS, INC. · MOSAIC IMMUNOENGINEERING, INC. · Denali Therapeutics Inc. · ELOXX PHARMACEUTICALS, INC. · enGene Therapeutics Inc. · ENTERA BIO LTD.

Stock screener

Watchlist